Nerea Irigoyen facts for kids
Quick facts for kids
Nerea Irigoyen
|
|
|---|---|
| Born |
Nerea Irigoyen Vergara
1981 |
| Nationality | Spanish |
| Alma mater |
|
| Scientific career | |
| Fields | Virology |
| Institutions | |
| Thesis | Analysis of the assembly and maturation processes of the Infectious Bursal Disease Virus capsid (2009) |
| Doctoral advisor | José Francisco Rodríguez Aguirre |
Nerea Irigoyen Vergara is a scientist from Zaragoza, Spain, born in 1981. She is a virologist, which means she studies viruses. Nerea is an expert in the Zika virus. She leads a research team at Cambridge University in the UK.
Contents
Discovering Viruses
Nerea Irigoyen first studied Pharmacy at the University of Navarra in Spain. Then, she earned her PhD at the CNB-CSIC in Madrid. During her studies, she spent time in Trieste, Italy, and Cambridge, UK.
After finishing her PhD, she moved to the University of Cambridge. There, she worked as a postdoctoral researcher. She was part of Professor Ian Brierley's team in the Virology Division. She also helped manage a project funded by the Medical Research Council.
Fighting Diseases
In 2018, Nerea Irigoyen started her own research group. Her team began to explore new ways to study cells infected by viruses. They focused on the Zika virus, but also looked at other viruses like coronavirus and retrovirus.
When the COVID-19 pandemic started, her group changed their focus. They worked hard to study SARS-CoV-2, the virus that causes COVID-19. They also developed new ways to fight these types of infections using medicines.
Connecting Scientists
Nerea Irigoyen is one of the people who helped start the Society of Spanish Researchers in the UK (SRUK/CERU). This group helps Spanish scientists living and working in the UK connect with each other. They also share scientific information with the public and work with Spanish authorities.
Important Research Papers
Nerea Irigoyen has written many important scientific papers. Here are a few of them:
- Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection. This paper, from 2021, looked at ways to fight coronavirus infections.
- Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Also from 2021, this research explored a new way to fight a type of blood cancer.
- Hybrid gene origination creates human-virus chimeric proteins during infection. This 2020 paper studied how new proteins can form when viruses infect humans.
- An upstream protein-coding region in enteroviruses modulates virus infection in gut epithelial cells. From 2019, this paper explored how some viruses infect cells in the gut.
See also
In Spanish: Nerea Irigoyen for kids
